|
Protagenic Therapeutics to Present at the BioFinance 2011 Conference New York - May 25, 2011 - Protagenic Therapeutics., Inc. announced today that it will be a presenter at the BioFinance 2011 conference at the St. Andrew’s Club & Conference Centre in Toronto, ON. This presentation will be given by David A. Lovejoy, Ph.D., Chief Scientific Officer, June 1, 2011 in the Room # 2 at 2:45 p.m. Eastern Time. Dr. Lovejoy will provide an overview of the company Research and Development programs, including PT00114 (a natural peptide hormone), which plays a key role in mood and addictive disorders. About BioFinance BioFinance is the leading investor conference in Canada for the life sciences industry. This event brings together key industry players interested in investment opportunities and issues affecting companies in the life sciences sector. Presenting companies span a range of industries including: biologics, medical devices, drug delivery, vaccines, diagnostics, bio-energy, green technologies, bio materials, industrial biotech, and research services. For more information visit the BioFinance website. About Protagenic Therapeutics Protagenic Therapeutics has created a proprietary portfolio of novel neuropeptides, which are in various stages of development and preclinical evaluation for the treatment of neuropsychiatric and mood based disorders. For further information please contact us at: May 25, 2011 Protagenic Therapeutics to Present at the BioFinance 2011 Conference. PDF
|
 |
